Science-backed wellness solutions for energy, weight control, and cellular health
A CMS demonstration program running July 1, 2026 through December 31, 2027
Step 1: Identify Primary Goal Step 2: Consider Your Routine Step 3: Evaluate Skin Type Step 4: Finalize Administration Method SeekPeptides members get access to personalized protocol recommendations based on individual goals and existing routines
An oral glucose tolerance test (OGTT) was performed prior to treatment and 43 days after the treatment to assess baseline glycemic control and ensure comparable glucose responsiveness across all treatment groups
As a GLP-1 receptor agonist, Ozempic works by regulating appetite, slowing gastric emptying, and promoting satiety, which can help reduce overall calorie intake
Patients with a history of retinopathy should be monitored by their provider and ophthalmologist during treatment